ChromaDex Q2 Sales $22.739M Miss $23.437M Estimate
Portfolio Pulse from Benzinga Newsdesk
ChromaDex (NASDAQ:CDXC) reported Q2 sales of $22.739 million, missing the analyst consensus estimate of $23.437 million by 2.98%. However, this represents an 11.89% increase over the same period last year.
August 07, 2024 | 8:54 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ChromaDex reported Q2 sales of $22.739 million, missing the analyst estimate of $23.437 million by 2.98%. Despite the miss, sales increased by 11.89% year-over-year.
The miss on sales estimates by 2.98% is likely to have a negative short-term impact on the stock price. However, the year-over-year increase of 11.89% may mitigate some of the negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100